01:22 PM EDT, 06/06/2025 (MT Newswires) -- Nkarta ( NKTX ) said Friday it appointed Shawn Rose as chief medical officer, effective June 23.

He will succeed David Shook, who is stepping down to pursue other opportunities in oncology, the company said.

The company added that during the transition, Rose will work with Shook, who will be a consultant through July 11.

Rose was most recently chief development officer, immunology, at Vividion Therapeutics, Nkarta ( NKTX ) said.

The company's shares rose 3% in recent trading.

Price: 1.89, Change: +0.05, Percent Change: +3.01